These findings are consistent with several studies utilizing case-control and prospective cohort study designs in the United States, Europe, and Asia, as well as systematic reviews that have reported an increased risk of BC with elevated levels of CRP [14, 15, 22–25]. The gene discussed is CRP; the disease is breast cancer.